-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the listing application of Shandong Lukang Pharmaceutical's 4 generic drug rosuvastatin calcium tablets has entered the administrative approval stage
Source: official website of the State Food and Drug Administration
Rosuvastatin is a selective and competitive HMG-CoA reductase inhibitor.
At present, more than 20 domestic companies have production approvals for rosuvastatin calcium tablets.
Sales of terminal blood lipid regulators in physical pharmacies in cities in China (unit: ten thousand yuan)
Source: Mi Nei.
According to data from Mi Nei.
2021E China's city entity drugstore terminal blood lipid regulator TOP5 products
Source: Mi Nei.
The market concentration of terminal blood lipid regulators in physical pharmacies in Chinese cities is relatively high.
From the perspective of the competitive landscape of manufacturers, the end-lipid regulator market in China's urban physical pharmacies is dominated by multinational companies.
Note: Minainet database, official website of State Food and Drug Administration, etc.
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories